Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MediQuest Therapeutics

Request full access

Topical therapies for inflammatory and infectious diseases

Bothell, United StatesFounded 1994Biotech & Life Sciences

About MediQuest Therapeutics

MediQuest Therapeutics, Inc. was a specialty biopharmaceutical company that developed therapeutics for treating inflammatory and infectious diseases. Founded in 2002 and based in Seattle, Washington, the company focused on creating treatments based on its proprietary topical amphiMatrix (TAM) drug delivery technology. This system was designed to deliver active agents through thickened skin and nails to the site of inflammation or infection.

The company's pipeline included clinical-stage products targeting conditions such as Raynaud's phenomenon, nail psoriasis, and actinic keratosis. One of its notable projects was MQX-503, a topical formulation for treating Raynaud's Disease, which showed positive results in a Phase III study by reducing symptom severity with minimal side effects. Over its lifetime, MediQuest Therapeutics raised a total of $22 million in funding over four rounds, with investors including Novo Holdings and Janus Henderson Investors. The company, which was also formerly known as Origen Corporation and Oridigm Corporation, is now listed as out of business.

Source: Dealroom company data

MediQuest Therapeutics in the Bothell ecosystem

Live from Dealroom

The MediQuest Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US National Institute of Allergy and Infectious Diseases

Series A6 investors entered at this stage

  • Integra Ventures
  • Novo Seeds
  • Janus Capital Group
  • Novo Holdings
  • Masa Life Science Fund
  • Novo Ventures
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Bothell HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MediQuest Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MediQuest Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.